Patients won't get vital pancreatic cancer drug that can extend life on the NHS

Hundreds of patients with advanced disease will be denied Abraxane, which extends life by two months when there are virtually no other options after experts decided the drug was not cost effective enough.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news